CEN Biotech, Inc.
CENBFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6526
P/E Ratio—
52W High$0.0002
52W Low$0.00001
CEN Biotech, Inc. (CENBF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CENBF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.99M | $0.63M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.49M | $0.00M | $0.44M | $2.58M | $4.37M |
| Gross Profit | $0.50M | $0.63M | ($0.44M) | ($2.58M) | ($4.37M) |
| Gross Margin %(computed) | 50.45% | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.04M |
| G&A Expenses | $2.25M | $18.33M | $2.21M | $2.58M | $3.10M |
| Total Operating Expenses | $1.76M | $19.66M | $1.77M | $2.58M | $3.10M |
| Operating Income | ($1.26M) | ($19.04M) | ($2.21M) | ($2.58M) | ($3.10M) |
| Operating Margin %(computed) | -128.15% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.01M | $0.01M | $0.01M |
| Interest Expense | $0.25M | $0.85M | $3.68M | $3.31M | $2.87M |
| Income Before Tax | ($1.51M) | ($18.94M) | $14.25M | ($5.66M) | ($7.53M) |
| Income Tax Expense | $0.00M | ($0.04M) | $0.00M | $0.00M | ($0.29M) |
| Net Income | ($1.51M) | ($18.90M) | $14.25M | ($5.66M) | ($7.53M) |
| Net Margin %(computed) | -153.48% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.45 | $0.52 | $-0.35 | $-0.30 |
| Wtd Avg Shares | 64.74M | 42.42M | 31.44M | 26.36M | 25.30M |
| EBITDA | ($0.77M) | ($17.63M) | $18.36M | ($1.90M) | ($4.22M) |
| EBITDA Margin %(computed) | -78.31% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more CEN Biotech, Inc. data
About CEN Biotech, Inc. (CENBF) Income Statement
CEN Biotech, Inc. (CENBF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, CENBF reported revenue of $0.00B, gross profit of $0.00B (gross margin 50.45%), and net income of ($0.00B) — a net profit margin of -153.48%.
Frequently asked questions
CENBF · 4 questionsCEN Biotech, Inc. (CENBF) reported revenue of $0.00B for 2022, up 57.5% year-over-year.
CENBF revenueCENBF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09